Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Current Assets: 2021-2024

Historic Current Assets for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $164,398.

  • ProQR Therapeutics N.V's Current Assets rose 28.24% to $130,152 in Q3 2025 from the same period last year, while for Sep 2025 it was $130,152, marking a year-over-year increase of 28.24%. This contributed to the annual value of $164,398 for FY2024, which is 25.62% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Current Assets of $164,398 as of FY2024, which was up 25.62% from $130,873 recorded in FY2023.
  • In the past 5 years, ProQR Therapeutics N.V's Current Assets ranged from a high of $226.6 million in FY2021 and a low of $130,873 during FY2023.
  • In the last 3 years, ProQR Therapeutics N.V's Current Assets had a median value of $164,398 in 2024 and averaged $52.6 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Current Assets crashed by 99.92% in 2023, and later climbed by 25.62% in 2024.
  • ProQR Therapeutics N.V's Current Assets (Yearly) stood at $226.6 million in 2021, then plummeted by 30.46% to $157.6 million in 2022, then plummeted by 99.92% to $130,873 in 2023, then increased by 25.62% to $164,398 in 2024.